R.F. Kornelisse

Dr. R.F. Kornelisse is a Researcher at Erasmus MC specializing in Neonatal and Pediatric Intensive Care. With an extensive publication record of 79 research outputs, Dr. Kornelisse's work primarily focuses on neonatal critical care, sepsis management, and pharmacokinetics in neonates and infants.

Dr. Kornelisse's research interests span across several critical areas in neonatology including:

• Neonatal sepsis diagnosis and management
• Pharmacokinetics and antibiotic dosing in neonates
• Neonatal intensive care unit (NICU) infections
• Antenatal corticosteroid administration in high-risk pregnancies
• Gestational age-related outcomes in neonates
• Blood culture diagnostics for early-onset sepsis

Analysis of Dr. Kornelisse's recent publications (2024-2025) reveals a strong focus on optimizing treatment protocols for neonates, particularly in the areas of sepsis management and antibiotic therapy. The research demonstrates a multidisciplinary approach combining clinical neonatology, infectious disease management, and pharmacokinetic modeling to improve outcomes for vulnerable neonatal populations. Much of the work involves large multicenter cohort studies that provide robust evidence for clinical practice, including research on clavulanic acid pharmacokinetics, antenatal corticosteroid timing, and PCR testing for sepsis diagnosis.

Dr. Kornelisse has collaborated extensively with researchers across Dutch medical institutions on neonatal care topics, contributing to important clinical guidelines in the field. The research has gained attention in academic circles with citations and mentions in news outlets, blogs, and social media platforms.